TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Kappa Bioscience AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 292,105 | 232,071 | 296,226 |
Financial expenses | 22,245 | 43,945 | 16,625 |
Earnings before taxes | 67,303 | 68,965 | 86,724 |
Total assets | 470,980 | 358,271 | 289,544 |
Current assets | 214,758 | 257,079 | 194,647 |
Current liabilities | 145,652 | 91,208 | 90,028 |
Equity capital | 254,083 | 230,199 | 191,064 |
- share capital | 1,521 | 1,521 | 1,521 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 53.9% | 64.3% | 66.0% |
Turnover per employee | |||
Profit as a percentage of turnover | 23.0% | 29.7% | 29.3% |
Return on assets (ROA) | 19.0% | 31.5% | 35.7% |
Current ratio | 147.4% | 281.9% | 216.2% |
Return on equity (ROE) | 26.5% | 30.0% | 45.4% |
Change turnover | 60,034 | -64,155 | 93,239 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.